Sponsor:
University of Toronto
Code:
NCT07258576
Conditions
Female Sex Hormones
Menstrual Cycle
Oral Contraceptives
Protein Metabolism
Eligibility Criteria
Sex: Female
Age: 18 - 40
Healthy Volunteers: Accepted
Interventions
Protein Beverage
Stable Isotope Tracer [D5]phenylalanine
Stable Isotope Tracer [13C]phenylalanine
Brief summary:
Conditions
Female Sex Hormones
Menstrual Cycle
Oral Contraceptives
Protein Metabolism
Study ID
NCT07258576
Start date
Jul 20, 2025
Status verified date
Nov, 2025
Completion date
Sep 1, 2026
Anticipated
Primary completion date
Sep 1, 2026
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 40
Healthy Volunteers: Accepted
Enrollment
20 participants
Anticipated
Allocation
Randomized
Intervention Model
Crossover
Primary purpose
Basic Science
Arms
other: Mid-Luteal Phase
other: Early Follicular Phase
other: Active Pill Phase
other: Placebo Pill Phase
Interventions
Protein Beverage
Stable Isotope Tracer [D5]phenylalanine
Stable Isotope Tracer [13C]phenylalanine
Primary outcome measure
Central contacts
Ines Kortebi, PhD Candidate
ines.kortebi@mail.utoronto.caLocations
Goldring Center for High Performance Sport
Recruiting
Toronto, Ontario, Canada, M5S 2C9
Contacts
Sponsor
University of Toronto
Last update posted
Dec 2, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Toronto on 2025-12-02.